Table 3. Toxicity according to CTCAE4.0.
| Type of toxic reaction | Total (n=88) | Pem + S-1 + Bev (n=21) | Other regimens (n=67) | P value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| All grade | 3/4 grade | All grade | 3/4grade | All grade | 3/4 grade | All grade | 3/4 grade | ||||
| Blood system, n (%) | |||||||||||
| Leukopenia | 30 (34.1) | 10 (11.4) | 11 (52.4) | 3 (14.3) | 19 (28.4) | 7 (10.4) | 0.043* | 0.929 | |||
| Neutropenia | 30 (34.1) | 14 (15.9) | 11 (52.4) | 6 (28.6) | 19 (28.4) | 8 (11.9) | 0.043* | 0.14 | |||
| Agranulocytosis | 0 | 0 | 0 | 0 | 0 | 0 | – | – | |||
| Anemia | 19 (21.6) | 1 (1.1) | 4 (19.0) | 0 | 15 (22.4) | 1 (1.5) | 0.983 | 0.761 | |||
| Thrombocytopenia | 16 (18.2) | 2 (2.3) | 5 (23.8) | 0 | 11 (16.4) | 2 (3.0) | 0.658 | 0.578 | |||
| Bleeding | 2 (2.3) | 0 | 1 (4.8) | 0 | 1 (1.5) | 0 | 0.368 | – | |||
| Digestive system, n (%) | |||||||||||
| Loss of appetite | 5 (5.7) | 0 | 2 (9.5) | 0 | 3 (4.5) | 0 | 0.74 | – | |||
| Nausea and vomiting | 1 (1.1) | 0 | 0 | 0 | 1 (1.5) | 0 | 0.761 | – | |||
| Diarrhea | 1 (1.1) | 0 | 0 | 0 | 1 (1.5) | 0 | 0.761 | – | |||
| Elevated alanine aminotransferase | 12 (13.6) | 0 | 4 (19.0) | 0 | 8 (11.9) | 0 | 0.643 | – | |||
| Elevated aspartate aminotransferase | 20 (22.7) | 0 | 4 (19.0) | 0 | 16 (23.9) | 0 | 0.871 | – | |||
| Elevated bilirubin | 6 (6.8) | 0 | 2 (9.5) | 0 | 4 (6.0) | 0 | 0.946 | – | |||
| Urinary system, n (%) | |||||||||||
| Elevated serum creatinine | 1 (1.1) | 0 | 0 | 0 | 1 (1.5) | 0 | 0.761 | – | |||
| Elevated blood urea nitrogen | 2 (2.3) | 0 | 0 | 0 | 2 (3.0) | 0 | 0.578 | – | |||
| Proteinuria | 10 (11.4) | 0 | 6 (28.6) | 0 | 4 (6.0) | 0 | 0.014* | – | |||
| Hematuria | 6 (6.8) | 0 | 2 (9.5) | 0 | 4 (6.0) | 0 | 0.946 | – | |||
| Other regimens, n (%) | |||||||||||
| Fatigue | 2 (2.3) | 0 | 1 (4.8) | 0 | 1 (1.5) | 0 | 0.368 | – | |||
| Rash | 3 (3.4) | 0 | 1 (4.8) | 0 | 2 (3.0) | 0 | 0.423 | – | |||
| Oral ulcer | 1 (1.1) | 0 | 0 | 0 | 1 (1.5) | 0 | 0.761 | – | |||
| Edema | 1 (1.1) | 0 | 0 | 0 | 1 (1.5) | 0 | 0.761 | – | |||
*, P<0.05. Pem, Pemetrexed; Bev, Bevacizumab.